Biostage appoints Joseph Damasio as CFO

Aug. 08, 2022 5:08 PM ETBiostage, Inc. (BSTG)By: Jessica Kuruthukulangara, SA News Editor1 Comment
  • Biostage (OTC:BSTG) said Monday it appointed Joseph Damasio as CFO.
  • Damasio's recent experience includes CFO, VP finance and controller roles at Inhibikase Therapeutics, Cue Biopharma and Pressure Biosciences.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.